You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美康生物:入選寧波市開展新型冠狀病毒核酸檢測單位
格隆匯 02-11 18:57

格隆匯2月11日丨美康生物(300439.SZ)公佈,公司於2020年2月11日收到寧波市新型冠狀病毒感染的肺炎疫情防控工作領導小組辦公室下發的《關於印發寧波市復工企業員工新冠病毒核酸檢測工作方案的通知》(甬防辦【2020】38號),公司入選為寧波市開展新型冠狀病毒核酸檢測單位。

《通知》指出:按照國務院有關文件和《關於進一步做好企業受控復工和返工人員管理的指導意見》(省疫情防控辦【2020】27號)要求,全面落實《關於做好疫情防控期間企業復工有關工作的通知》(甬防【2020】9號)和《寧波市疫情防控期間企業復工管理實施細則》(甬防辦【2020】36號),為科學有序促進企業復工,並綜合考慮寧波市相關企業的檢測能力、檢測資質和檢測經驗等各因素,經寧波市新型冠狀病毒感染的肺炎疫情防控工作領導小組同意,確定公司入選為寧波市開展新型冠狀病毒核酸檢測工作的檢測單位,負責區域為寧波餘姚市、慈溪市、鎮海區、鄞州區、寧波杭州灣新區、東錢湖,檢測對象為上述區域內復工企業返崗和返甬員工等。

公司入選為寧波市開展新型冠狀病毒核酸檢測單位,有利於公司拓展本地的醫學診斷服務市場,但公司目前尚無法預測其對公司未來業績的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account